311770-42-0

Basic information

• Product Name: ethyl 3-(3-carboxy-4-methoxyphenyl)-2-ethylpropanoate
• Synonyms: ethyl 3-(3-carboxy-4-methoxyphenyl)-2-ethylpropanoate
• CAS NO: 311770-42-0
• Molecular Weight: 280.321
• Mol File: 311770-42-0.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: ethyl 3-(3-carboxy-4-methoxyphenyl)-2-ethylpropanoate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 3-(3-carboxy-4-methoxyphenyl)-2-ethylpropanoate(311770-42-0)
• EPA Substance Registry System: ethyl 3-(3-carboxy-4-methoxyphenyl)-2-ethylpropanoate(311770-42-0)

Safety Data

• Hazardous Substances Data: 311770-42-0(Hazardous Substances Data)

Upstream product

• 84923-70-6 5-formyl-2-methoxybenzoic acid 
• 17145-91-4 triethyl 2-ethylphosphonoacetate 
• 311770-43-1 ethyl (3-benzyloxycarbonyl-4-methoxyphenyl)-2-ethylacrylate 
• 311770-86-2 benzyl 5-formyl-2-methoxybenzoate 

Downstream Products

• 311770-49-7 ethyl 2-ethyl-3-[4-methoxy-3-[N-[[4-(trifluoromethyl)phenyl]-methyl]carbamoyl]phenyl]propanoate 

Relevant articles and documents

Design and synthesis of substituted phenylpropanoic acid derivatives as human peroxisome proliferator-activated receptor α/δ dual agonists

A series of phenylpropanoic acids was prepared as candidate dual agonists of peroxisome proliferator-activated receptors (PPAR) α and δ. Structure-activity relationship studies indicated that the shape of the linker moiety and the nature of the substituen

Design, synthesis, and evaluation of substituted phenylpropanoic acid derivatives as human peroxisome proliferator activated receptor activators. Discovery of potent and human peroxisome proliferator activated receptor α subtype-selective activators

Substituted phenylpropanoic acid derivatives were prepared as part of a search for subtype-selective human peroxisome proliferator activated receptor α (PPARα) activators. Structure-activity relationship studies indicated that the nature and the stereoche

SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES AS AGONISTS TO HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA(PPAR)

The invention provides novel substituted phenylpropanoic acid derivatives that activate by binding to receptor as ligands of human peroxisome preliferant-activated receptor α (PPARα), and exhibit potent decreasing action on lipids in blood (cholesterol and triglyceride). It relates to substituted phenylpropanoic acid derivatives represented by a general formula (1), their pharmaceutically acceptable salts and their hydrates, and processes for preparing them.